Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001144204-18-033608

Options or other derivatives

  • Chief Science Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PICKER DONALD H Chief Science Officer 2018-06-06 Grant or award · Stock option (right to buy) +75,000 135,000 D
Loading xslF345X03/tv496092_4.xml…